
Metomac H 50mg/12.5mg Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Metoprolol Succinate (50mg) + Hydrochlorothiazide (12.5mg)
Overview Metomac H 50mg/12.5mg Tablet ER
Cardiovasc H 50mg/12.5mg Extended-Release Tablets manage hypertension (high blood pressure) when monotherapy proves insufficient. This medication contributes to blood pressure regulation and diminishes the risk of future strokes and heart attacks. Prompt administration enhances survival rates following a heart attack. Take Cardiovasc H 50mg/12.5mg ER tablets with or without food, preferably in the morning, to minimize nocturnal urination. Continue treatment as prescribed; discontinuation, even with symptom improvement, can worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further support blood pressure control. Follow your physician's guidance meticulously. Common side effects include nausea, constipation, diarrhea, and fatigue; consult your doctor if these persist, worsen, or are bothersome. Increase fluid intake to alleviate potential dryness, weakness, or thirst. Dizziness or headaches (due to potential hypotension) necessitate slow rising from a seated position and caution when driving. Prior to initiating treatment, disclose any kidney or liver ailments. Pregnant or lactating individuals require medical consultation before use. Inform your doctor of all concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, blood glucose, and electrolyte levels (potassium, magnesium) is essential to assess treatment efficacy.
Primary Ingredients of Metomac H 50mg/12.5mg Tablet ER
No information provided. Please provide the text you wish to be rewritten.
Uses of Metomac H 50mg/12.5mg Tablet ER
Elevated arterial blood pressure
Major Benefits of Metomac H 50mg/12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metomac H 50mg/12.5mg Extended-Release tablet whole; do not damage it in any way. While food isn't required, consistent timing is recommended for optimal results.
Common Side effects of Metomac H 50mg/12.5mg Tablet ER:
- Fatigue
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Metomac H 50mg/12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metomac H 50mg/12.5mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. While food is not required, consistency is key—take it at the same time each day.
How Metomac H 50mg/12.5mg Tablet ER works:
Metomac H 50mg/12.5mg Extended-Release tablets combine metoprolol succinate, a beta-blocker, and hydrochlorothiazide, a diuretic, to effectively manage hypertension. Metoprolol succinate acts directly on the heart, slowing the heart rate and enhancing its pumping efficiency. Hydrochlorothiazide reduces blood pressure by promoting fluid and electrolyte excretion, leading to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metomac H 50mg/12.5mg Extended-Release Tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metomac H 50mg/12.5mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metomac H 50mg/12.5mg tablets are likely safe for breastfeeding mothers. Available evidence from human studies indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metomac H 50mg/12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when prescribing Metomac H 50mg/12.5mg Tablet ER to individuals with severe renal impairment; dosage modification may be necessary. A physician's consultation is advised. Metomac H 50mg/12.5mg Tablet ER is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Metomac H 50mg/12.5mg Extended-Release tablets. Dosage modification of Metomac H 50mg/12.5mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metomac H 50mg/12.5mg Tablet ER :
Should you forget a dose of Metomac H 50mg/12.5mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metomac H 50mg/12.5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
